A detailed history of Vident Advisory, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 95,822 shares of PFE stock, worth $2.62 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
95,822
Holding current value
$2.62 Million
% of portfolio
0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $2.42 Million - $2.84 Million
95,822 New
95,822 $2.68 Billion
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $103,265 - $134,130
-3,952 Reduced 6.64%
55,541 $1.6 Billion
Q3 2023

Feb 21, 2024

BUY
$32.09 - $37.51 $126,819 - $148,239
3,952 Added 7.12%
59,493 $1.97 Billion
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $1.91 Million - $2.23 Million
59,493 New
59,493 $1.97 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.